Search research articles
Contact Us
Filters
Showing results (201-210 of 228) with videos related to
Page
of 23
Sort By:
The Journal of Pathology
|
January 30, 1999
Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma
E Pilozzi, K Pulford, M Jones, et al.
Blood
|
November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)
B Falini, L Flenghi, M Fagioli, et al.
Leukemia
|
July 4, 2008
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family
G Cazzaniga, L Lo Nigro, I Cifola, et al.
Leukemia
|
April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B Falini, D Lenze, R Hasserjian, et al.
Blood
|
November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
B Falini, K Pulford, A Pucciarini, et al.
Blood
|
March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
B Falini, M Fizzotti, A Pucciarini, et al.
Leukemia
|
March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
P Gorello, G Cazzaniga, F Alberti, et al.
Leukemia
|
August 7, 2009
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma
S Eckerle, V Brune, C Döring, et al.
International Journal of Cancer
|
June 8, 2000
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity
L Leoncini, S Lazzi, D Scano, et al.
The Journal of Pathology
|
November 26, 1997
Antigen retrieval techniques in immunohistochemistry: comparison of different methods
S A Pileri, G Roncador, C Ceccarelli, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 228) with videos related to
Sort By:
Page
of 23
The Journal of Pathology
|
January 30, 1999
Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma
E Pilozzi, K Pulford, M Jones, et al.
Blood
|
November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)
B Falini, L Flenghi, M Fagioli, et al.
Leukemia
|
July 4, 2008
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family
G Cazzaniga, L Lo Nigro, I Cifola, et al.
Leukemia
|
April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B Falini, D Lenze, R Hasserjian, et al.
Blood
|
November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
B Falini, K Pulford, A Pucciarini, et al.
Blood
|
March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
B Falini, M Fizzotti, A Pucciarini, et al.
Leukemia
|
March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
P Gorello, G Cazzaniga, F Alberti, et al.
Leukemia
|
August 7, 2009
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma
S Eckerle, V Brune, C Döring, et al.
International Journal of Cancer
|
June 8, 2000
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity
L Leoncini, S Lazzi, D Scano, et al.
The Journal of Pathology
|
November 26, 1997
Antigen retrieval techniques in immunohistochemistry: comparison of different methods
S A Pileri, G Roncador, C Ceccarelli, et al.
Page
of 23